Rayonier Advanced Materials RYAM Biomaterials and other — Net Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Rayonier Advanced Materials in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Rayonier Advanced Materials’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rayonier Advanced Materials's biomaterials and other — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Rayonier Advanced Materials's biomaterials and other — net sales?
- Rayonier Advanced Materials (RYAM) reported biomaterials and other — net sales of $12.62M in Q1 2026.
- What does biomaterials and other — net sales mean?
- This metric represents the total revenue generated from the sale of products within the company's biomaterials and ancillary business units. It reflects the commercial performance of non-core or specialized chemical and material offerings derived from wood-based feedstocks. Monitoring this figure helps investors assess the company's diversification strategy and the market adoption of its emerging sustainable material technologies.